Navigation Links
Medicaid Data Analysis

An analysis of Medicaid data released today from five states indicates that psychiatric and substance abuse services may be missing their mark if they are limited to community settings, such as community clinics and therapists offices.

Although most intervention policies for co-occurring substance abuse and mental disorders are community-based, a significant number of people with co-occurring disorders never appear in these settings, said study co-author Robin E. Clark, Director of Research, Center for Health Policy and Research, University of Massachusetts Medical School. Substance abuse actually lowers the odds of being treated in a community setting.

The study, funded by the Robert Wood Johnson Foundations Substance Abuse Policy Research Program (SAPRP), shows that when Medicaid beneficiaries have co-occurring disorders, their odds of inpatient and emergency department use and hospital-based psychiatric treatment go up and use of community services goes down, as compared to beneficiaries with just one disorder.

This pattern was clear both for persons with severe and less severe mental disorders. The study was published in the July 2007 issue of Psychiatric Services.

This is occurring despite the fact that primary care studies indicate that continuity of treatment is weaker and costs are higher in hospital settings and data suggest that people treated in these settings have higher rates of inpatient treatment, the authors say.

We need to provide treatment to people wherever they appear in the treatment system instead of increasing treatment in one settingsuch as the community-based settingand hoping they come there, said Clark.

Psychiatric disorders and substance abuse are major problems for the Medicaid population. Diagnosed psychiatric and substance use disorders are from fifty percent to one hundred percent more prevalent among Medicaid beneficiaries than in the general popula tion. Medicaid funds half of state and local support of mental illness treatments and one-third of specialty substance abuse treatment.

The authors set out to understand where integrated psychiatric and substance abuse services may need to be provided for Medicaid beneficiaries. They examined the location of services used by persons with mental and substance use disorders from 1999 Medicaid data obtained from the Centers for Medicare and Medicaid Services for five states: Arkansas, Colorado, Indiana, New Jersey, and Washington.

Robin E. Clark, Ph.D., and Mihail Samnaliev, Ph.D., at the Center for Health Policy and Research, University of Massachusetts Medical School, and Mark P. McGovern, Ph.D., Psychiatric Research Center, Dartmouth Medical School, analyzed whether beneficiaries with co-occurring disorders were treated in community-based settings, inpatient facilities, emergency departments, or hospital outpatient departments.

The full dataset of close to 126,513 beneficiaries ages 21 through 64 included 17,952 Medicaid beneficiaries with co-occurring disorders. Three-fourths of patients with co-occurring disorders were younger than age 45. Racial and ethnic minorities made up a substantial proportion of the population, ranging from 20.8% in Indiana to 61.2% in New Jersey.

Heavy inpatient and emergency department use were common among Medicaid beneficiaries with co-occurring disorders. One in five beneficiaries treated in these settings received no Medicaid funded behavioral health treatment elsewhere. Beneficiaries with co-occurring disorders were three to six times more likely to be hospitalized for psychiatric treatment during 1999 than were those with a mental health diagnosis alone.

Arkansas was the one state in which co-occurring disorders did not reduce the odds that patients would receive community-based mental health treatment. The authors suggest that reimbursement policies favoring com munity mental health centers may increase the likelihood of receiving community treatment.

Calling for a no wrong door approach for Medicaid populations, the authors conclude that attempts to improve mental health and substance abuse treatment for Medicaid beneficiaries with co-occurring disorders should be broad based, focusing on hospital inpatient, emergency department, and outpatient services as well as on community based providers.

In fact, Promising brief interventions for co-occurring disorders designed especially for emergency departments and trauma centers are currently available, says Clark.


'"/>




Related medicine news :

1. Medicaid cuts leave patients in a lurch
2. Homecare Association Highlights Cost-Effectiveness of Medicare and Medicaid
3. Misplaced Priorities in Medicaid Dispensation
4. Bush Administration to Exempt Medicaid Recipients on Proof of Citizenship
5. Few Medicaid Kids with Asthma Get Recommended Flu Shot
6. Medicaid Security Riddled with Flaws
7. Lowest Spending growth in US Medicaid
8. New Medicaid Rule For New Borns
9. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
10. Meta Analysis Links Diabetes And Colorectal Cancer
11. NASA Analysis Say 2005 Was The Warmest Year
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/15/2017)... ... January 15, 2017 , ... Whole Health Supply, LLC is announcing the release of an ... new avenues for purchase. , The 2017 edition has wide jaws that will accommodate ... older boomers as well as diabetics. This handle is reinforced for extra strength when pressing ...
(Date:1/15/2017)... CA (PRWEB) , ... January 15, 2017 , ... ... their choice of best physicians in eight Bay Area counties for 2017. Almost ... the healthcare research company managing the award process. Results were announced the magazine’s ...
(Date:1/15/2017)... ... 15, 2017 , ... The JPR Group, a public relations ... it will be assisting HackensackUMC Mountainside with its public relations efforts, effective January ... surrounding towns. The firm will be working closely with HackensackUMC Mountainside’s internal marketing ...
(Date:1/14/2017)... ... January 14, 2017 , ... AgileMinder develops innovative products and services ... Scale is now available on Apple as a fun, free emoji sticker pack for ... one of the ten color coded values on The Emoji Scale. , On ...
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: ... hotel on March 3-4, 2017. This Congress is expertly designed to meet the ... of patients with lung cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... -- Research and Markets has announced the addition of ... their offering. ... Global multiple myeloma drugs market to grow at a CAGR of ... the present scenario and the growth prospects of the global multiple ... report considers the revenue generated from the sales of branded and ...
(Date:1/16/2017)... 16, 2017  This report by Persistence Market ... market for the period 2016–2024. The primary objective ... information related to market opportunities in the global ... study demonstrates the various dynamics that are expected ... of the global peripherally inserted central catheters market ...
(Date:1/16/2017)... 16, 2017 Derek H. Potts , ... was recently appointed Liaison Counsel in California,s ... Xarelto cases. In this role, Potts was assigned to ... actively assist the Court and Co Lead Plaintiff,s Counsel. ... Adelman Jackson Fairchild & Wade and Ruth ...
Breaking Medicine Technology: